Management of Essential Tremor prioritizes functional improvement over symptom elimination, and protocols begin with propranolol or primidone.

The Food and Drug Administration approved the Exablate Neuro system as the first focused ultrasound device intended to treat essential tremor in patients who do not respond to conventional medication.

Essential tremor (ET) is the most common type of tremor disorder, affecting approximately 7 million people in the United States.¹ It causes involuntary, rhythmic shaking, most often in the hands, ...

Please provide your email address to receive an email when new articles are posted on . A Bay Area bioelectronic medicine company announced the commercial launch of its next-generation Cala kIQ System ...

The FDA cleared an artificial intelligence (AI)-powered wristband (Felix NeuroAI) to treat upper-limb functional limitations in adults with essential tremor, device maker Fasikl announced. The ...

As we age, performing daily tasks and the activities we enjoy can become more difficult. Some seniors may begin experiencing movement disorders that further inhibit their physical abilities and the ...

Essential tremor is one of the most common movement disorders, yet it often is mistaken for other neurological conditions such as Parkinson’s disease. Affecting an estimated 7 to 10 million Americans, ...

BURLINGAME, Calif.--(BUSINESS WIRE)--Cala Health, Inc., a bioelectronic medicine company developing wearable therapies for chronic disease, announced that the U.S. Food and Drug Administration (FDA) ...

--Wristband is a first-of-its-kind investigational wearable designed to provide dynamic, all-day, personalized relief for people with essential tremor (ET); powered by advanced AI to continuously ...